Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Beacon Equity Research Featured Company: National Pharmaceuticals Corp. (NFRM)

|Includes: Ntl Pharmaceuticals (NFRM)

National Pharmaceuticals Corp. is a pharmaceutical research and development company dedicated to leading edge technologies for treatment of human diseases. The company has focused its efforts on the business of licensing mid stage development drugs for further development and marketing worldwide.

The company’s lead therapeutic drug is believed to have significant effects on the management of pain due to trauma, wound, and accidents, as well as autoimmune conditions. Under the internal name GLB333, the cytokine functions differently than current pain killers or analgesics. It helps to rebuild the damage tissues, reduces inflammatory conditions and helps to regenerate good and healthy muscle and soft tissues.

Globe Laboratories has worked on the biology and use of GLB333 for several years and has invested considerable resources on its development. The company retains the worldwide exclusive license to the use and marketing of the product, although the license carries standard terms and conditions used by other companies in this sector.

Please see disclaimer on the QualityStocks website: